2. Learning Objectives
• Define shock
• Stages of shock
• Classifications of shock
• Approach to the Patient in Shock
• ABCDEs
3. What is shock?
• Inadequate perfusion to meet tissue demands.
A progressive process.
– Occurs in 2% of hospitalized patients.
– Mortality 10% in children, vs. 30-40% in adults.
• In other words, a systemic reduction in tissue
perfusion decreased tissue O2 delivery.
– A shift to less-efficient anaerobic metabolism, leading to lactic acidosis.
• Initially, effects are reversible. Eventually:
– Cell membrane ion pump dysfunction
– Cellular edema, leakage of cells’ contents
– Inadequate regulation of intracellular pH
– Cell death, organ failure, cardiac arrest, and death.
4. Stages of Shock
A progressive process: Intervene early
• Compensated Shock: Cardiac output
(HR x SV) and systemic vascular resistance (peripheral
vasoconstriction) work to keep BP within normal.
– On exam: Tachycardia; decreased pulses & cool extremities in cold shock;
flushing and bounding pulses in warm shock; oliguria; labs may show mild
lactic acidosis
• Hypotensive (Uncompensated) Shock: Compensatory
mechanisms are overwhelmed.
– On exam: As above, plus hypotension, altered mental status; labs may show
increased lactic acidosis
– Generally quick progression to cardiac arrest.
• Irreversible Shock: Irreversible organ damage, cardiac arrest,
death occur.
5. Multiorgan Dysfunction Syndrome (MODS)
• Progression of physiologic effects as shock
ensues
• Cardiac depression
• Respiratory distress
• Renal failure
• DIC
• Result is end organ failure
6. Classifications of Shock
• Hypovolemic Shock
– Decreased preload due to
internal or external losses.
• Distributive Shock
– Decrease in SVR, with
abnormal distribution
of blood flow
functional
hypovolemia,
decreased preload.
– Typically, NL or CO.
Cardiogenic Shock
“Pump failure.” CO,
systolic function.
Obstructive Shock
Outflow from left or right
side of heart physically
obstructed.
Anaphylactic shock
Anaphylaxis is a severe, life-
threatening, generalised or
systemic
hypersensitivity reaction.
7. Physiologic profiles of shock states
Type of Shock Preload
(PCWP)
Cardiac
Output
Afterload
(SVR)
Tissue
Perfusion
(Mixed venous sat)
Hypovolemic
Distributive Or
=
Or
=
Cardiogenic *
Obstructive
8. Approach to the Patient in Shock
• ABCs
• Cardiorespiratory monitor
• Pulse oximetry
• Supplemental oxygen
• IV access
• ABG, labs
• Foley catheter
• Vital signs including rectal temperature
9. Approach to the Patient in Shock
• History
• Recent illness
• Fever
• Chest pain, SOB
• Abdominal pain
• Comorbidities
• Medications
• Toxins/Ingestions
• Recent hospitalization or
surgery
• Baseline mental status
• Physical examination
• Vital Signs
• CNS – mental status
• Skin – color, temp, rashes,
sores
• CV – JVD, heart sounds
• Resp – lung sounds, RR,
oxygen sat, ABG
• GI – abd pain, rigidity,
guarding, rebound
• Renal – urine output
10. Is This Patient in Shock?
• Patient looks ill
• Altered mental status
• Skin cool and mottled or
hot and flushed
• Weak or absent
peripheral pulses
• SBP <110
• Tachycardia
Yes!
These are all signs and
symptoms of shock
11. Goals of Treatment
• ABCDE-- Airway, Breathing, Circulation, Disability, Exposure
• Airway
• control work of Breathing
• optimize Circulation
• assure adequate oxygen Delivery
• achieve End points of resuscitation
12. Airway
• Determine need for intubation but remember:
intubation can worsen hypotension
• Sedatives can lower blood pressure
• Positive pressure ventilation decreases preload
• May need volume resuscitation prior to
intubation to avoid hemodynamic collapse
13. Control Work of Breathing
• Respiratory muscles consume a significant
amount of oxygen
• Tachypnea can contribute to lactic acidosis
• Mechanical ventilation and sedation decrease
WOB and improves survival
14. Optimizing Circulation
• Isotonic crystalloids
• Titrated to:
• CVP 8-12 mm Hg
• Urine output 0.5 ml/kg/hr (30 ml/hr)
• Improving heart rate
• May require 4-6 L of fluids
• No outcome benefit from colloids
• Elevating lower limbs helps increase venous return with
vasodilatation.
15. Maintaining Oxygen Delivery
• Decrease oxygen demands
• Provide analgesia and anxiolytics to relax muscles
and avoid shivering
• Maintain arterial oxygen saturation/content
• Give supplemental oxygen
• Maintain Hemoglobin > 10 g/dL
• Serial lactate levels or central venous oxygen
saturations to assess tissue oxygen extraction
16. End Points of Resuscitation
• Goal of resuscitation is to maximize survival
and minimize morbidity
• Use objective hemodynamic and
physiologic values to guide therapy
• Goal directed approach
• Urine output > 0.5 mL/kg/hr
• CVP 8-12 mmHg
• MAP 65 to 90 mmHg
• Central venous oxygen concentration > 70%
17. Anaphylactic shock
• Anaphylaxis is a severe, systemic allergic
reaction
• multisystem involvement, including the skin,
airway, vascular system, and GI
• Severe cases may result in complete
obstruction of the airway, cardiovascular
collapse, and death
18.
19. Drugs Inducing Anaphylaxis
– Antibiotics (especially parenteral penicillins and
other ß-lactams),
(Because they are obtained from microbes)
Aspirin and NSAIDs
intravenous (IV) contrast agents are the most
frequent medications associated with life-
threatening anaphylaxis.
20. Epinephrine
• Administer epinephrine by IM injection early
to all patients with signs of a systemic
reaction, especially hypotension, airway
swelling, or definite difficulty breathing.
• Use a rapid progression to high dose without
hesitation in patients in full cardiac arrest.
• A commonly used sequence is 1 to 3 mg IV (3
minutes), 3 to 5 mg IV (3 minutes), then 4 to
10 µg/min infusion
21. • Administer IV epinephrine if anaphylaxis
appears to be severe with immediate life-
threatening manifestations
• Use epinephrine (1:10 000) 0.1 mg IV slowly
over 5 minutes. Epinephrine may be diluted to
a 1:10 000 solution before infusion.
• An IV infusion at rates of 1 to 4 µg/min may
prevent the need to repeat epinephrine
injections frequently
22. The Use of Adrenaline in Anaphylaxis
The problems with its use:
•Variable Absorption - give I.m. AVOID s.c.
•Arrhythmogenic in high dose - NEVER give 1:1000 ADRENALINE I.v.
If using ADRENALINE as an IVI, it must be diluted and do not delay
administration of ADRENALINE to set up IVI and gain IV access.
Therefore:
1. Give ADRENALINE I.m promptly (can repeat at 5-10 min intervals)
2. Gain IV access
3. If patient remains in shock resort to IV Iine thus ….
Dilute 0.5ml of 1:1000 ADRENALINE in 50ml of N/saline
(1:100,000)
4. Infuse at 0.1-2ml/min (1-20ug/min) until haemodynamically
stable
5. If using prolonged IVI, add renal-dose of DOPAMINE IVI.
23. Other Drugs
• Antihistamine IV. There is little data about the value of
antihistamines in anaphylactic cardiac arrest, but it is
reasonable to assume that little additional harm could result
• Administer antihistamines slowly IV or IM (eg, 25 to 50 mg of
diphenhydramine)
• Corticosteroids Infuse high-dose IV
corticosteroids early in the course of therapy.
Beneficial effects are delayed at least 4 to 6
hours.
24. Aggressive volume expansion
profound vasodilation
Increases intravascular capacity
Massive volume replacement is needed.
At least 2 large-bore IVs with pressure bags to
administer large volume (typically between 4
and 8 L) of isotonic crystalloid (infusions of
NS, DNS, )as quickly as possible
25. Potential Therapies
• Vasopressin. There are case reports that vasopressin may
benefit severely hypotensive patients.
• Atropine. Case reports suggest that when relative or severe
bradycardia is present, there may be a role for administration
of atropine.
• Glucagon. For patients who are unresponsive to epinephrine,
especially those receiving ß-blockers, glucagon may be
effective. This agent is short-acting; give 1 to 2 mg every 5
minutes IM or IV. Nausea, vomiting, and hyperglycemia are
common side effects